DNV lands second Chilean aquaculture deal in a week with Aquabench
What's the deal? Norwegian assurance and risk management firm DNVDealroom has a profile for this one. Try Dealroom → has agreed to acquire a majority stake in Aquabench, a Chilean provider of data, analytics, and decision support to the salmon industry. Terms were not disclosed.
Why now? The deal lands just days after DNV bought a majority stake in AqualisDealroom has a profile for this one. Try Dealroom →, a Chilean inspection and certification firm for aquaculture infrastructure, announced October 14. Two acquisitions in a week signal a deliberate push into Chile, the world's second-largest farmed salmon producer.
What each side brings: Aqualis certifies and inspects farm infrastructure, while Aquabench runs a neutral information platform built on a database of production, environmental, and fish-health data. Together they give DNV both physical assurance and the data layer behind it.
What's the endgame? The moves build on DNV's March acquisition of AquaCloudDealroom has a profile for this one. Try Dealroom → technology, part of a broader effort to create shared data infrastructure for aquaculture. DNV plans to use Aquabench to speed services in fish health, biosecurity, environmental analysis, and sustainability, and to develop Salmobench, its digital intelligence platform for Chilean salmon.
"Aquaculture companies are facing increasingly stringent requirements related to traceability, sustainability and operational efficiency," said Joel Leal, general manager of Aquabench. "This investment gives us the opportunity to strengthen our role as an independent knowledge partner."
What changes for customers? DNV said Aquabench will keep its independent role and local focus while tapping DNV's global network. Both companies pledged to maintain standards for confidentiality, data security, and data governance.
"With DNV as a majority owner, Aquabench will have an even stronger foundation for developing new offerings and delivery models," said Geir Fuglerud, chief executive of DNV's Life Sciences division.
The signal: DNV is consolidating complementary capabilities in a single market as salmon producers face mounting biological and regulatory pressure. The strategy is clear, but with terms undisclosed, the financial scale and impact remain hard to gauge.
Read more: fishfarmingexpert.com
Image credit: Sam Beebe
